| Authors: |
Beijert IJ; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands., Hentschel AE; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands., Bründl J; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany., Compérat EM; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Pathology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France., Plass K; European Association of Urology, Guidelines Office Board, Arnhem, The Netherlands., Rodríguez O; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain., Subiela Henríquez JD; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain., Hernández V; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain., de la Peña E; Department of Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain., Alemany I; Department of Pathology, Hospital Universitario Fundación Alcorcón, Madrid, Spain., Turturica D; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy., Pisano F; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy., Soria F; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy., Čapoun O; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic., Bauerová L; Department of Pathology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic., Pešl M; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic., Maxim Bruins H; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands., Runneboom W; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Herdegen S; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany., Breyer J; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany., Brisuda A; Department of Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic., Calatrava A; Department of Pathology, Fundación Instituto Valenciano de Oncología, Valencia, Spain., Rubio-Briones J; Department of Urology, Fundación Instituto Valenciano de Oncología, Valencia, Spain., Seles M; Department of Urology, Medical University of Graz, Graz, Austria., Mannweiler S; Department of Pathology, Medical University of Graz, Graz, Austria., Bosschieter J; Department of Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands., Kusuma VRM; Department of Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK., Ashabere D; Department of Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK., Huebner N; Department of Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria., Cotte J; Department of Urology, Pitié Salpétrière Hospital, AP-HP, GRC no. 5, Oncotype-Uro, Sorbonne University, Paris, France., Mertens LS; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Masson-Lecomte A; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands., Liedberg F; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands., Cohen D; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Royal Free Hospital, Royal Free London NHS Foundation Trust, London, UK., Lunelli L; Department of Urology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France., Cussenot O; Department of Urology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France., El Sheikh S; Department of Pathology, Royal Free Hospital, Royal Free London NHS Foundation Trust, London, UK., Volanis D; Department of Urology, Royal Free Hospital, Royal Free London NHS Foundation Trust, London, UK., Côté JF; Department of Pathology, Pitié Salpétrière Hospital, AP-HP, Pierre et Marie Curie Medical School, Sorbonne University, Paris, France., Rouprêt M; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Pitié Salpétrière Hospital, AP-HP, GRC no. 5, Oncotype-Uro, Sorbonne University, Paris, France., Haitel A; Department of Pathology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria., Shariat SF; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic; Department of Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria., Mostafid AH; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK., Nieuwenhuijzen JA; Department of Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands., Zigeuner R; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, Medical University of Graz, Graz, Austria., Dominguez-Escrig JL; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, Fundación Instituto Valenciano de Oncología, Valencia, Spain., Hacek J; Department of Pathology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic., Zlotta AR; Department of Surgical Oncology (Urology), University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada., Burger M; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands., Evert M; Department of Pathology, University of Regensburg, Regensburg, Germany., Hulsbergen-van de Kaa CA; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., van der Heijden AG; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands., A L M Kiemeney L; Department of Health Evidence and Urology, Radboud University Medical Center, Nijmegen, The Netherlands., Soukup V; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic., Molinaro L; Department of Pathology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy., Gontero P; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy., Llorente C; Department of Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain., Algaba F; Department of Pathology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain., Palou J; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain., N'Dow J; European Association of Urology, Guidelines Office Board, Arnhem, The Netherlands., Ribal MJ; European Association of Urology, Guidelines Office Board, Arnhem, The Netherlands., van der Kwast TH; Laboratory Medicine Program, University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada., Babjuk M; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic; Department of Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria., Sylvester RJ; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands., van Rhijn BWG; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Surgical Oncology (Urology), University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada. Electronic address: b.v.rhijn@nki.nl. |
